← Eichor
Condition: Kidney Renal Cell Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Kidney Renal Cell Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT05899361Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients Wi
Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT04240054A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC
Phase 2 · 1 location(s) · Peking University First Hospital · NCT06889649National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Phase N/A · 27 location(s) · PROspective Renal Cancer Cohort Foundation · NCT05326620CD70-targeted immunoPET Imaging of Kidney Cancer
Phase 2 · 1 location(s) · RenJi Hospital · NCT06680089Cabozantinib Dose Skipping as an Alternative to Dose Reductions
Phase 2 · 1 location(s) · dr. Tom van der Hulle · NCT07077161Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 · 7 location(s) · Sairopa B.V. · NCT05856981A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 47 location(s) · Bristol-Myers Squibb · NCT04895709Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NA · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06138067International Multicentric Study ARON-1
Phase N/A · 1 location(s) · Hospital of Macerata · NCT05287464A Multicenter Cancer Biospecimen Collection Study
Phase N/A · 1 location(s) · Cofactor Genomics, Inc. · NCT04510129A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Ce
Phase 1 · 11 location(s) · Neomorph, Inc · NCT073002419MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 · 2 location(s) · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT06823427A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
Phase 2 · 1 location(s) · Jinling Hospital, China · NCT06255223Preop Laxatives in Robotic Urologic Surgery
Phase 4 · 1 location(s) · Chad R. Tracy · NCT05805436VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Phase 2 · 1 location(s) · Mayo Clinic · NCT07510334CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Phase 2 · 5 location(s) · Jinling Hospital, China · NCT07615348At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Se
Phase 1 · 3 location(s) · Molecure S.A. · NCT05759923Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-c
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT06623630DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Phase 1/Phase 2 · 23 location(s) · 3D Medicines (Sichuan) Co., Ltd. · NCT05024214Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
NA · 6 location(s) · Niels Fristrup · NCT03977571CAIX PET/ CT Guided Radiation Therapy in CcRCC.
NA · 1 location(s) · Peking University First Hospital · NCT07540260
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.